𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Differential expression of markers in extensive and restricted Langerhans Cell Histiocytosis (LCH)

✍ Scribed by Ferenc KŐhalmi; János Strausz; Márta EgervÁry; György Szekeres; József TímáR

Book ID
112932666
Publisher
Springer Netherlands
Year
1996
Tongue
English
Weight
630 KB
Volume
2
Category
Article
ISSN
1219-4956

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

LCH-I: A randomized trial of etoposide v
LCH-I: A randomized trial of etoposide vs. vinblastine in disseminated langerhans cell histiocytosis
✍ Ladisch, Stephan ;Gadner, Helmut ;Arico, Maurizio ;Broadbent, Valerie ;Grois, Ni 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 403 KB

## Abstract An international randomized trial in Langerhans cell histiocytosis (LCH) has been initiated by the Histiocyte Society. This report reviews the rationale, design, and progress of LCH‐I, which compares etoposide (VP‐16) and vinblastine in the treatment of disseminated LCH. Data on the ris

Report of the Histiocyte Society Worksho
Report of the Histiocyte Society Workshop on “Central Nervous System (CNS) Disease in Langerhans Cell Histiocytosis (LCH)”
✍ Grois, N.; Broadbent, V.; Favara, B. E.; D'Angio, G. 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 88 KB 👁 3 views

Central nervous system (CNS) manifestations of Langerhans cell histiocytosis (LCH) remain among the major enigmas of this puzzling disease. The Histiocyte Society therefore covened a workshop on CNS LCH at the time of its 1996 meeting in Vienna, Austria. Prof. H. Gadner and Dr. N. Grois undertook th

2-chlorodeoxyadenosine (2-CDA) for the t
2-chlorodeoxyadenosine (2-CDA) for the treatment of refractory or recurrent Langerhans cell histiocytosis (LCH) in pediatric patients
✍ Stine, Kimo C.; Saylors, Robert L.; Williams, Laura L.; Becton, David L. 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 192 KB 👁 2 views

Background. Pediatric patients with Langerhans cell histiocytosis (LCH) may become refractory to conventional therapy or present with repeated recurrences over several years. Current therapeutic options such as prednisone, vinblastine, etoposide, and cyclosporine are associated with significant acut